[Retracted] Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes

Table 2

Comparison of the syndrome scores of the two groups of patients.

	Control (n = 40)		Research (n = 40)
	Before treatment	After treatment	Before treatment	After treatment
Sneeze	2.38 ± 0.61	1.60 ± 0.59	2.41 ± 0.58	1.29 ± 0.44
tcontrol-research/Pcontrol-research		2.664/0.0094
Running nose	2.40 ± 0.54	1.44 ± 0.54	2.39 ± 0.52	1.09 ± 0.33
tcontrol-research/Pcontrol-research		3.498/0.0008
Nasal obstruction	2.09 ± 0.61	1.56 ± 0.35	2.13 ± 0.58	1.26 ± 0.43
tcontrol-research/Pcontrol-research		3.422/0.001
Rhinocnesmus	1.88 ± 0.35	1.55 ± 0.34	1.89 ± 0.37	1.14 ± 0.56
tcontrol-research/Pcontrol-research		3.907/0.0002
Total score	8.73 ± 1.31	6.18 ± 1.42	8.70 ± 1.27	4.87 ± 1.34
tcontrol-research/Pcontrol-research		4.244/0.0001